Predilife

The company's capital structure is heavily leveraged, with total liabilities of EUR 6,711,790 and total equity of EUR -4,268,110, resulting in a debt-to-equity ratio of -1.16. Liquidity is constrained, as evidenced by a current ratio of 1.37 and negative free cash flow of EUR -4,238,640. The company's return on assets is negative at -1.7452, indicating poor asset utilization.

Profitability is severely challenged, with a net loss of EUR -4,264,750 and an operating loss of EUR -4,499,150. The return on equity is 0.9992, which is not a typical measure of profitability due to the negative equity base. The company's gross profit of EUR 479,380 is significantly lower than its operating and net losses, suggesting high operational costs.

The company's revenue is concentrated in a single segment, with no disclosed geographic diversification. This lack of diversification increases the risk associated with market-specific downturns.

The company's growth trajectory is negative, with a net loss and declining operating cash flow. Analyst estimates suggest continued financial pressure, with a mean EPS estimate of -1.20 EUR and a mean revenue estimate of 690,000 EUR. The company's capital expenditure is minimal at EUR -5,400, indicating a lack of investment in future growth.

The company faces significant financial risks, including liquidity constraints and a high debt burden. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag.

Recent events, including the latest financial filings, indicate ongoing financial distress. The company's financial performance has not met analyst expectations, with a last actual EPS of -1.14 EUR.